Shares in C4X Discovery Holdings PLC have rocketed after the company licensed a potential best-in-class addiction candidate to fellow UK firm Indivior PLC in a deal that could be worth up to $294m.
The pact, for which C4XD is getting $10m up front and a further $284m of potential development, regulatory and commercialization...